Clinical Trials
9 trialsNCT05947383 2026-05-06
2Dose
Sunstone Medical
Phase 2 Active not recruiting
NCT06801041 2026-04-16
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06319378 2026-04-13
CAPSI
Section for Affective Disorders; Northern Stockholm Psychiatry
Phase 2 Recruiting
NCT00302744 2025-03-13
Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Phase 1/2 Completed
NCT04522804 2024-03-20
HOPE
University of Utah
Phase EARLY_PHASE1 Completed
NCT05042466 2022-11-16
NWTTPS
NWTraumatherapies
Phase 1 Unknown
NCT04593563 2021-10-15
The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder
Maryland Oncology Hematology, PA
Phase 2 Unknown
NCT00957359 2020-10-20
Psilocybin Cancer Anxiety Study
NYU Langone Health
Phase EARLY_PHASE1 Completed
NCT00465595 2018-07-19
Psychopharmacology of Psilocybin in Cancer Patients
Johns Hopkins University
Phase 2 Completed